Thank you for following HEDIMED!

HEDIMED project has come to an end

After a long journey that started in 2020, the HEDIMED project has now officially concluded. Along the way we have gained valuable new insights into the links between the exposome and immune-mediated diseases – with more still to come in the form of collaboration and upcoming publications!

We warmly thank all our followers and collaborators for being part of this journey!

The HEDIMED website will remain open five years, and we aim to advertise our publications on our remaining LinkedIn page regularly.

In addition, The EHEN network website will remain open for five years. Make sure to get familiar with the great collection of tools from each project! If you want to keep track of the broader exposome research, we encourage you to follow the IHEN network.

Wishing you a refreshing autumn!

Best regards,

HEDIMED Admin Team

Should you have any inquiries regarding HEDIMED, please contact us by using our Contact form or admin team’s personal emails.

Similar Posts

  • HEDIMED @ EASD2024

    A quick throwback into EASD2024, held in Madrid in 9th-13th September: This year, EASD brought together a large and engaged audience of more than 12,000 people, with particular interest in Type 1 Diabetes. The event, designed to bridge the gap between scientific discoveries and public health, featured key presentations and discussions about the disease. HEDIMED…

  • Consortium meeting in Malmo

    Project consortium meeting took place in 8th-9th December ’22 in Malmo, Sweden. The 2-day meeting consisted of workshops, small working groups, and updates from laboratories and the project in general. This time we managed to gather more than 60 attendees in-place. Toxicant, celiac disease as well as exosome group meetings took place already in pre-meeting…

  • Project catch-up

    After a busy first half of the year, we want to wrap up some past events and highlight the upcoming ones. Our science has taken big steps and we are glad to announce that some practical steps, such as samples transfers to different laboratories are in active phase, meaning lab analyses are also ongoing and…

  • Hedimed Kickoff

    12-14th of February 2020 In February 2020 the entire HEDIMED consortium gathered together for the first time in a three-day kick-off meeting in Tampere Hall, Tampere, Finland. In a total of 87 participants attended the face-to-face meeting and spent long but productive days getting to know the details of the project and meeting the other…

  • Faecal volatilomics in exposome research

    Novel Technologies used in HEDIMED Volatile organic compounds (VOCs) are substances that readily evaporate in our ordinary living environment. This means that they have a high vapour pressure at room temperature and low boiling point, which facilitates their volatility and makes them responsible for odours and smells. VOCs are a diverse group of compounds derived…